Episode Details
Back to Episodes
Rising Young Adult Cancer Rates, MaaT Pharma's ALS Therapy Shows Promise, EVE-Vax Transforms Vaccine Design, Exploring New Immunity Research, and more...
Published 1 year, 2 months ago
Description
(0:10): Study Reveals Alarming Rise in Early-Onset Cancers Among Young Adults, Calls for Urgent Action
(2:43): MaaT Pharma's ALS Trial Shows Promise with Safe Microbiome Therapy, Slows Disease Progression
(5:13): EVE-Vax Revolutionizes Vaccine Design with Synthetic SARS-CoV-2 Spike Proteins
(7:14): Exploring Innate Immunity: New Collection Focuses on Pattern Recognition Receptors and Microbiome Interactions
(9:01): Energy Drinks Pose Grave Health Risks for Youth: Urgent Call for Regulation
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Daily Sabah
(2:43): MaaT Pharma's ALS Trial Shows Promise with Safe Microbiome Therapy, Slows Disease Progression
(5:13): EVE-Vax Revolutionizes Vaccine Design with Synthetic SARS-CoV-2 Spike Proteins
(7:14): Exploring Innate Immunity: New Collection Focuses on Pattern Recognition Receptors and Microbiome Interactions
(9:01): Energy Drinks Pose Grave Health Risks for Youth: Urgent Call for Regulation
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Daily Sabah